MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Positron emission tomography(PET)"

  • 2025 International Congress

    Metabolic network signature of quantitative motor effects following deep brain stimulation in Parkinson’s disease

    A. Calvano, A. Turan, U. Kleinholdermann, V. Heinecke, K. Steidel, L. Ruesing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjuergen, M. Luster, L. Timmermann, C. Eggers, M. Ruppert-Junck, D. Pedrosa (Marburg, Germany)

    Objective: To integrate [18F]-FDG PET (fPET) and objective motor performance to unravel metabolic networks associated with deep brain stimulation (DBS) outcomes in Parkinson’s disease (PD).…
  • 2025 International Congress

    Effect of Exenatide on disease progression in early Parkinson’s disease–a randomized, placebo controlled, single-center trial in Sweden

    I. Markaki, CC. Tang, PE. Papathoma, L. Hainke, W. Paslawski, J. Paslawska, I. Savitcheva, U. Estenberg, D. Eidelberg, P. Svenningsson (Solna, Sweden)

    Objective: To identify biological mechanisms that mediate Exenatide's effect in the brain of patients with early Parkinson’s disease(PD). Background: Tracking PD progression remains a major challenge due to…
  • 2025 International Congress

    The value of PET imaging in Parkinson’s disease with cognition impairment

    T. Hu, Y. Tang, J. Wang (Shanghai, China)

    Objective: The purpose of this study was to explore the diagnostic value of PET imaging, plasma biomarkers in the diagnosis of cognitive dysfunction in Parkinson's…
  • 2025 International Congress

    Decreased cholinergic activity in specific brain regions associated with slower lower limb visual choice reaction time in Parkinson’s disease: A [18F]-FEOBV PET study

    P. Kanel, G. Carli, J. Barr, F. Michalakis, S. Roytman, R. Vangel, P. Scott, C. Pongmala, R. Albin, N. Bohnen (Ann. Arbor, USA)

    Objective: To investigate the relationship between cholinergic system changes, as measured by vesicular acetylcholine transporters (VAChT) [18F] fluoroethoxybenzovesamicol ([18F] FEOBV) binding in PET, and cognitive performance, measured as…
  • 2025 International Congress

    Brain Energetics: Changes in Healthy Aging and Parkinson’s Disease

    C. Bevington, S. Dhaliwal, J. Mckenzie, A. Stoessl, V. Sossi (Vancouver, Canada)

    Objective: To identify in vivo bioenergetic alterations in healthy aging and Parkinson’s disease (PD). Background: PD-related cerebral metabolic alterations have been robustly characterized [1] and…
  • 2024 International Congress

    18F-Florzolotau Positron Emission Tomography Imaging Correlates with Regional Brain Atrophy and Plasma Biomarkers in Tauopathy Parkinsonism Syndrome

    CH. Li, SP. Fan, MC. Shih, YH. Weng, TF. Chen, IT. Hsiao, KJ. Lin, CH. Lin (Hsinchu, Taiwan)

    Objective: We aim to investigate the relationship between regional 18F-florzolotau uptake and clinical severity, structural volume changes, and plasma markers in tauopathy parkinsonism syndrome. Background:…
  • 2024 International Congress

    Mitochondrial Complex I Brain Imaging in Parkinson’s Disease and Lewy Body Dementia

    S. Berman, J. Stehouwer, C. Mathis, W. Klunk, H. Tsukada, S. Royse, A. Reese, T. Overbey, J. Greenamyre, G. Sjobeck, D. Tudorascu, B. Lopresti (Pittsburgh, USA)

    Objective: To compare brain mitochondrial respiratory Complex-1 (mito-C1) between Parkinson’s disease (PD) and PD dementia/Dementia with Lewy Bodies (PDD/DLB) participants and unimpaired controls, using 18F-BCPP-EF,…
  • 2024 International Congress

    Altered [18F]VAT Uptake Supports Cholinergic Dysfunction in Isolated Adult-Onset Cervical Dystonia

    N. Goldman, J. O'Donnell, A. Tanenbaum, J. Lee, J. Perlmutter, S. Norris (St Louis, USA)

    Objective: Our aim is to investigate whether altered cholinergic function is associated with isolated adult-onset cervical dystonia (CD). Background: Animal models and clinical observations suggest…
  • 2024 International Congress

    Metabolic Progressive Subtypes in Progressive Supranuclear Palsy

    H. Wang (Hangzhou, China)

    Objective: To investigate disease-specific spatiotemporal progression in Progressive supranuclear palsy (PSP) patients using 18F-fluorodeoxyglucose (FDG) PET and the Subtype and Stage Inference (SuStaIn) algorithm, to…
  • 2024 International Congress

    Metabolic characteristics of brain network in patients with Parkinson’s disease after Deep brain stimulation

    WEI. Lin, LJJ. Jin, KLY. Yang, HYW. Wang (WUXI CITY, China)

    Objective: The purpose of this study is to observe the short-term brain metabolic network characteristics of Parkinson's disease patients after STN DBS treatment through PET-CT…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley